Digital Health

Also, new mobile applications promoting mental wellbeing have been launched.

Also, a Taiwanese startup has received the US FDA's 510(k) clearance for its neurosurgical robot.

The company offers mental healthcare for children and their families and will use the funds to expand its reach.

The announcement comes the same week the pharma giant ended its collaboration with Hims & Hers to sell Wegovy, alleging the company engages in deceptive marketing and illegally sells copycat drugs.

Christopher McGhee says that, along with the acquisition, Current Health will have a "return to scrappiness and that startup spirit."

The company offers an AI-enabled workflow automation platform for administrative tasks pertaining to specialty medications. 

Connor Glass, founder and CEO of Phantom Neuro, discusses the company's muscle-machine interface that allows individuals with limb loss to control robotic limbs and systems using electrical activity from their own muscles.

Connor Glass, founder and CEO of Phantom Neuro, explains how the company's muscle-machine interface for amputees is enabling the development of advanced prosthetic limbs designed to function as natural extensions of the human body.

The company will use the funds to advance its AI-enabled robotic platform for cataract and other eye surgeries, with plans to begin human clinical trials this year.

The Series E funding comes four months after the company secured $250 million in a Series D round.